A federal judge this week denied federal prosecutors’ request to disqualify the law firm representing former Advanced Medical Optics CEO James Mazzo, despite misrepresentations by a former lawyer for Skadden Arps Slate Meagher & Flom. Mazzo was indicted in September 2014 on insider trading charges stemming from Abbott‘s (NYSE:ABT) $2.8 billion acquisition of AMO in 2009. Prosecutors accused Mazzo of tipping […]
Advanced Medical Optics
Mazzo suspended at Versant Ventures after insider trading indictment | Personnel Moves
Versant Ventures and James Mazzo agreed that Mazzo will "suspend any activities" at the venture capital shop following his indictment last month on insider trading charges.
Medtronic shareholder sues over company’s plan to cover nearly $58M in taxes | Medtech legal news for the week of October 13, 2014
Feds fight dismissal of charges in Abbott-AMO insider trading case
Ex-Oriole DeCinces fights insider trading charges
Ex-Oriole DeCinces fights insider trading charges
BSX loses $309M judgment in patent war with the family of Dr. Michel Mirowski | Medtech legal news for the week of September 29, 2014
Boston Scientific loses $309 million judgment in Mirowski patent war
September 24, 2014 by Brad Perriello
Ex-Advanced Medical Optics CEO Mazzo indicted in insider trading case
MassDevice.com Q&A: James Mazzo on his move to Versant Ventures
James Mazzo has put 35 years into the optics and ophthalmology business, so it was no surprise that he got involved with AcuFocus and its device for treating presbyopia. Mazzo, who stepped down from leading Abbott Medical Optics earlier this year, added another title to his resume that’s more of a departure: He’s the 1st "operating partner" at Versant Ventures.